Phase I Feasibility Study of the Combination of Fondaparinux (Arixtra) With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2014
At a glance
- Drugs Fondaparinux sodium (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer; Thromboembolism
- Focus Adverse reactions
- 31 Jan 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2015 as reported by ClinicalTrials.gov.
- 31 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Aug 2011 Planned End Date changed from 1 Jun 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.